Overview

IMS® DIAREG Diabetes Registry - Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus

Status:
Terminated
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This observation plan outlines the approach to build a diabetes registry to collect data on daily routine of treatment of Type 2 Diabetes Mellitus.
Details
Lead Sponsor:
IMS HEALTH GmbH & Co. OHG
Treatments:
Hypoglycemic Agents